Metraipolis › archive › dc_731f095eb4cd

Successful Use of Chimeric Antigen Receptor T-cell (CAR-T) Therapy With Lisocabtagene Maraleucel in a Renal Transplant Recipient With Refractory/Relapsed… — Europe PMC PMID:41853416

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41853416
DOI
10.7759/cureus.103667
License (as archived)
solo-consultazione
Archived
2026-11-05T19:24:55.088Z
SHA-256 of the archived text
132e5989a37a5bdc9754c5cffcfe6358ce055c36801fe2b64c92abd36f19e37a
Stable URL of this page
https://metraipolis.com/documento/dc_731f095eb4cd

How to cite

Successful Use of Chimeric Antigen Receptor T-cell (CAR-T) Therapy With Lisocabtagene Maraleucel in a Renal Transplant Recipient With Refractory/Relapsed… — Europe PMC PMID:41853416 — Europe PMC (en), https://europepmc.org/article/MED/41853416 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_731f095eb4cd (Metraipolis archive dc_731f095eb4cd, sha256 132e5989a37a5bdc9754c5cffcfe6358ce055c36801fe2b64c92abd36f19e37a)
BibTeX
@misc{dc731f095eb4cd,
  title = {Successful Use of Chimeric Antigen Receptor T-cell (CAR-T) Therapy With Lisocabtagene Maraleucel in a Renal Transplant Recipient With Refractory/Relapsed… — Europe PMC PMID:41853416},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41853416},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_731f095eb4cd; sha256 132e5989a37a5bdc9754c5cffcfe6358ce055c36801fe2b64c92abd36f19e37a},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41853416. Agents can read the archived copy with the MCP tool read_document.